This article contains some figures that are displayed in color online but in black-and-white in the print edition.
This is original work. It was presented at the 2012 meeting of the American Academy of Neurological Surgery, October 18, 2013.
Andrews DWScott CBSperduto PWFlanders AEGaspar LESchell MC: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–16722004
Chow EHarth THruby GFinkelstein JWu JDanjoux C: How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol (R Coll Radiol) 13:209–2182001
Linskey MEAndrews DWAsher ALBurri SHKondziolka DRobinson PD: The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:45–682010
Varlotto JMFlickinger JCNiranjan ABhatnagar AKondziolka DLunsford LD: The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 62:1125–11322005